These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 8874779

  • 1. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
    Pagel PS, Hettrick DA, Warltier DC.
    Basic Res Cardiol; 1996; 91(4):296-307. PubMed ID: 8874779
    [Abstract] [Full Text] [Related]

  • 2. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP, Pagel PS, Tessmer JP, Warltier DC.
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [Abstract] [Full Text] [Related]

  • 3. Desflurane, sevoflurane, and isoflurane impair canine left ventricular-arterial coupling and mechanical efficiency.
    Hettrick DA, Pagel PS, Warltier DC.
    Anesthesiology; 1996 Aug; 85(2):403-13. PubMed ID: 8712457
    [Abstract] [Full Text] [Related]

  • 4. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [Abstract] [Full Text] [Related]

  • 5. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs.
    Pagel PS, Hettrick DA, Warltier DC.
    Br J Pharmacol; 1996 Oct; 119(3):609-15. PubMed ID: 8894186
    [Abstract] [Full Text] [Related]

  • 6. Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure.
    Tachibana H, Cheng HJ, Ukai T, Igawa A, Zhang ZS, Little WC, Cheng CP.
    Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H914-22. PubMed ID: 15486041
    [Abstract] [Full Text] [Related]

  • 7. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
    Pagel PS, McGough MF, Hettrick DA, Lowe D, Tessmer JP, Jamali IN, Warltier DC.
    J Cardiovasc Pharmacol; 1997 May; 29(5):563-73. PubMed ID: 9213196
    [Abstract] [Full Text] [Related]

  • 9. Levosimendan potentiates the inotropic actions of dopamine in conscious dogs.
    McGough MF, Pagel PS, Lowe D, Hettrick DA, Warltier DC.
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):36-47. PubMed ID: 8797134
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
    Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM.
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
    [Abstract] [Full Text] [Related]

  • 11. Levosimendan restores the positive force-frequency relation in heart failure.
    Masutani S, Cheng HJ, Tachibana H, Little WC, Cheng CP.
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H488-96. PubMed ID: 21572004
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
    Udvary E, Papp JG, Végh A.
    Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
    [Abstract] [Full Text] [Related]

  • 13. Alterations in canine left ventricular-arterial coupling and mechanical efficiency produced by propofol.
    Hettrick DA, Pagel PS, Warltier DC.
    Anesthesiology; 1997 May; 86(5):1088-93. PubMed ID: 9158358
    [Abstract] [Full Text] [Related]

  • 14. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
    Axelsson B, Häggmark S, Svenmarker S, Johansson G, Gupta A, Tydén H, Wouters P, Haney M.
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
    [Abstract] [Full Text] [Related]

  • 15. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
    Kolseth SM, Wahba A, Kirkeby-Garstad I, Aro S, Nordgaard H, Høydal M, Rognmo Ø, Nordhaug D.
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
    [Abstract] [Full Text] [Related]

  • 16. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
    Kaheinen P, Pollesello P, Levijoki J, Haikala H.
    J Cardiovasc Pharmacol; 2004 Apr; 43(4):555-61. PubMed ID: 15085067
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ.
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [Abstract] [Full Text] [Related]

  • 18. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.
    Asanoi H, Ishizaka S, Kameyama T, Ishise H, Sasayama S.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757
    [Abstract] [Full Text] [Related]

  • 19. Effects of milrinone on left ventricular end-systolic pressure-volume relationship of rat hearts in situ.
    Kishi T, Nakahashi K, Ito H, Taniguchi S, Takaki M.
    Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):737-42. PubMed ID: 11553033
    [Abstract] [Full Text] [Related]

  • 20. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
    Kerbaul F, Gariboldi V, Giorgi R, Mekkaoui C, Guieu R, Fesler P, Gouin F, Brimioulle S, Collart F.
    Crit Care Med; 2007 Aug; 35(8):1948-54. PubMed ID: 17568324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.